• Protocols

• EA2183

  OPEN TO ACCRUAL

  Ph III Consolidative XRT in Pts w/ Oligometastatic HER2- Esophageal and Gastric Adenocarcinoma
  
  

• UW19029

  OPEN TO ACCRUAL

  P2- 5FU, oxaliplatin, nal-IRI & immunotherapy (+ trastuzumab for HER2+) for adv esophageal & gastric